Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Enters Alliance with Luxembourg Biobank

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies has inked an agreement with the Integrated Biobank of Luxembourg under which it will use Life Technologies' Applied Biosystems SOLiD System to sequence its biospecimen samples.

The IBBL is an independent, non-profit biobanking and biotech foundation that has focused initially on collecting, storing, analyzing, and distributing cancer biospecimen samples. It was co-founded in 2008 by Luxembourg's three public research centers — CRP-Santé, CRP-Henri Tudor, CRP-Gabriel Lippmann — the University of Luxembourg, and Arizona's Translational Genomics Research Institute.

Life Technologies said that the collaboration could result in a greater understanding of the genetic basis for many diseases and could eventually have application in using sequencing for clinical diagnostics.

"By partnering with Life Technologies, IBBL is gaining access to cutting-edge sequencing technology, an important step to building an advanced technology infrastructure and a successful biomedical research industry in Luxembourg," Jean-Claude Schmit, president of IBBL, said in a statement.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.